Product Information
TOPIRAMATE 50 MG TABLET is a generic product labeled by Quallent Pharmaceuticals Health LLC, priced at $0.0345 per EA under NDC 82009013605. Its NADAC has been published 141 times since Oct 18, 2023.
Strength
50 mg/1
Manufacturer
Quallent Pharmaceuticals Health LLCNDC
82009013605
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
TOPIRAMATEApproval Type
Generic (ANDA)
FDA Application
ANDA078235On Market Since
7/24/2023
Pharmacological Classes
Price Statistics
The NADAC for TOPIRAMATE 50 MG TABLET has been published 141 times since Oct 18, 2023, and over the history we have for it it has declined 15.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0345 per EA |
|---|---|
| All-time high | $0.0445 (Apr 10, 2024) |
| All-time low | $0.0319 (Nov 20, 2024) |
| 52-week high | $0.0394 |
| 52-week low | $0.0345 |
| Median price | $0.0391 |
| Average price | $0.0384 |
| Largest weekly change | +31.7% (Aug 21, 2024) |
| Weeks tracked | 141 |
| Tracking since | Oct 18, 2023 |
Generic Alternatives
The matcher finds 6 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 6 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of TOPIRAMATE 50 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for TOPIRAMATE 50 MG TABLET, manufactured by Quallent Pharmaceuticals Health LLC, is $0.0345 per EA (NDC 82009013605), effective Jun 24, 2026.
How has the price of TOPIRAMATE 50 MG TABLET changed over time?
Over the history we have for it, the NADAC for TOPIRAMATE 50 MG TABLET has declined 15.6%. It has been tracked across 141 weekly CMS publications since Oct 18, 2023.
What are the highest and lowest recorded NADAC prices for TOPIRAMATE 50 MG TABLET?
Since Oct 18, 2023, the NADAC for TOPIRAMATE 50 MG TABLET has ranged from a low of $0.0319 (Nov 20, 2024) to a high of $0.0445 (Apr 10, 2024), with a median of $0.0391 per EA.
Are there cheaper alternatives to TOPIRAMATE 50 MG TABLET?
6 NADAC-published products share the same active ingredient, strength, and dosage form as TOPIRAMATE 50 MG TABLET, but none are currently priced below it.
Who manufactures TOPIRAMATE 50 MG TABLET?
TOPIRAMATE 50 MG TABLET (NDC 82009013605) is labeled by Quallent Pharmaceuticals Health LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification